XML 36 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2014
SHAREHOLDERS' EQUITY [Abstract]  
Schedule of Stock Option Activity

 

  Year ended  

 

  December 31, 2014  

 

  Number     Weighted     Aggregate  

 

  of options     average exercise     intrinsic value  

 

  (thousands)     price (per share)     (1)  

    

                       

Outstanding at beginning of year

  1,715   $ 3.47   $ 11,809

Granted

  810   10.11  

Exercised

  (540 )   (1.57 )  

Forfeited

  (96 )   (9.97 )  
     

Outstanding at end of year

  $ 1,889   $ 6.53   $ 8,148
     

Vested and expected to vest at end of year

  $ 1,792   $ 6.36   $ 8,027
     

Exercisable at end of year

  $ 897   $ 3.22   $ 6,757



(1)
Calculation of aggregate intrinsic value for options outstanding and exercisable is based on the share price of the Company's ordinary shares as of December 31, 2014 which was $10.75 per share.
Schedule of Shares Authorized Under Stock Option Plans, by Exercise Price Range
        Outstanding     Exercisable  
                Weighted average                     Weighted average          
                remaining contractual     Weighted average             remaining contractual     Weighted average  
        Number outstanding     life     exercise     Number exercisable     life     exercise  
Exercise price     (thousands)     (years)     price     (thousands)     (years)     price  
$                     $                     $  
                               
$ 0.48 - $1.52     237     0.85     1.16     237     0.85     1.16  
2.00 - $3.44     556     2.69     2.86     538     2.67     2.85  
5.68 - $7.81     205     5.34     6.87     15     4.30     6.03  
8.04 - $9.87     378     5.30     9.14     74     4.41     8.72  
10.03 - $11.32     513     5.28     10.95     33     4.92     10.37  
                           
      1,889     3.97     $ 6.53     897     2.44     $ 3.22  
Schedule of Stock-Based Compensation Expense
 

Year ended
December 31,

 

 

2014

 

2013

   

2012 

 

                  

Research and development

  $ 440   $ 237     $ 306

Selling and marketing

  636     325     241

General and administrative

  413     184     189
         

Total stock-based compensation

  1,489     746     736